Semnur Pharmaceuticals, Inc. (OTCPK: SMNR)
Health Care · Pharmaceuticals · US
$0.84
+1.20% today · -93.0% 1Y
Semnur Pharmaceuticals, Inc. (OTCPK: SMNR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $193.38M.
Over the last twelve months the share price has lost 93.0%, trading between 0.25 and 23.00.
Tweenvest scores Semnur Pharmaceuticals, Inc. across four factors: quality 2/100. Its strongest factor is quality.
SMNR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $193.38M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.77
- Dividend yield
- —
- Beta (5Y)
- 0.02
- 52-week high
- $23.00
- 52-week low
- $0.25
- Avg volume (3M)
- —
- Shares outstanding
- 230.21M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.